A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2001
11/20/2001	US6319901 Providing therapeutic substance; establishing electrical field which encompasses region of tissue within patient; exposing region of tissue to electrical field to permit permeation; administering agent prolonging permeability of cell membranes
11/20/2001	US6319897 Peptides which inhibit complement activation
11/20/2001	US6319716 Generating expression vectors; link heterologous sequences, insert into cells, allow homologous recombination, recover expression vectors
11/20/2001	US6319711 Composition and method for inhibiting reverse transcript of a retrovirus
11/20/2001	US6319698 Method for producing arachidonic acid
11/20/2001	US6319689 Nucleotide sequence which code aspartic protease; for treatment of alzheimer's disease, cancer; for hormone processing
11/20/2001	US6319688 Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
11/20/2001	US6319667 Diagnostics and therapy of diseases associated with HHV-8 infections
11/20/2001	US6319520 Copolymers of ammonium methacrylate that consist of fully polymerized copolymers of acrylic acid and methacrylic acid ester having quaternary ammonium groups
11/20/2001	US6319519 Anti-inflammatory pharmaceutical formulations
11/20/2001	US6319518 Colon selective drug delivery composition
11/20/2001	US6319517 Pharmaceutical preparation comprising lyophilized liposomes encapsulating an active principle which is highly insoluble in water, and the process for preparing the said preparation
11/20/2001	US6319515 Isosorbide dinitrate-containing patch
11/20/2001	US6319514 Administering domperidone and a nsaid for eliciting analgesic and anti-inflammatory response and combating nausea in acute migraine attacks
11/20/2001	US6319510 Pad to be installed on gum comprising nonporous layer, adjacent layer retaining medication capable of being liquefied by saliva, semipermeable layer covering second layer and sealed to first layer to form pocket enclosing second layer
11/20/2001	US6319509 Pharmaceutical composition
11/20/2001	US6319498 Amyloidogenic protein, or fragment thereof, modified with cis-decalin group, cholanoyl structure, cholyl group, diethylenetriaminepentaacetyl group, menthoxyacetyl group, fluorescein-containing group, or n-acetylneuraminyl group
11/20/2001	US6319490 Liquid oral compositions comprising a calcium compound and an acidulant
11/20/2001	US6319464 Added to borate containing compound; antimicrobial activity enhancement
11/20/2001	US6319260 Method of endoscopic mucosal resection using mucopolysaccharide and local injection preparation
11/20/2001	US6319192 Method for the treatment of fertility disorders
11/20/2001	CA2311024C Pharmaceutical composition for oral administration of chelating agents
11/20/2001	CA2297163C Gaba analogs to prevent and treat gastrointestinal damage
11/20/2001	CA2257431C Fast-dissolving galanthamine hydrobromide tablet
11/20/2001	CA2217026C New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients
11/20/2001	CA2176668C Heterocyclic spiro compounds, process for preparing the same and pharmaceutical compositions containing them
11/20/2001	CA2174854C Quinazoline derivative
11/20/2001	CA2090404C Nonaqueous fluorinated drug delivery vehicle suspensions
11/20/2001	CA2086121C Ophthalmic suspensions
11/20/2001	CA2071971C The use of arginine as an immunostimulator
11/20/2001	CA2046126C 2-thienylglycidic derivative, process for its preparation and its use as synthesis intermediate
11/20/2001	CA2025599C Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
11/20/2001	CA2024843C Synthesis of mannojirimycin derivatives
11/20/2001	CA2018287C Use of rapamycin for preparing a composition for inhibiting organ or tissue transplant rejection, and composition for inhibiting transplant rejection
11/20/2001	CA2017851C Micronised biodegradable particles, process for preparing them and the use thereof
11/20/2001	CA2008116C Glycine derivatives
11/20/2001	CA2007786C Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase
11/19/2001	CA2308994A1 Neuroprotective compounds
11/18/2001	CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/18/2001	CA2345482A1 Use of paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby
11/15/2001	WO2001086307A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001	WO2001086002A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/15/2001	WO2001085983A2 Methods for testing compounds useful for treating diabetic complications
11/15/2001	WO2001085981A2 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085960A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	WO2001085953A1 Sphingosine kinase and uses thereof
11/15/2001	WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001	WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001	WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001	WO2001085926A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	WO2001085910A2 Agents that modulate dna-pk activity and methods of use thereof
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	WO2001085750A1 Uridine derivatives as antibiotics
11/15/2001	WO2001085749A1 Anti-viral pyrimidine nucleoside analogues
11/15/2001	WO2001085744A1 Immunostimulant compositions and associated methods
11/15/2001	WO2001085734A1 Benzoxazines for use in the treatment of parkinson's disease
11/15/2001	WO2001085733A1 Interstrand crosslinking agents for dna and compounds therefor
11/15/2001	WO2001085729A1 Novel vitronectin receptor antagonists
11/15/2001	WO2001085727A1 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists
11/15/2001	WO2001085726A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001	WO2001085725A1 Piperazine and piperidine compounds
11/15/2001	WO2001085724A1 Gastrin and cholecystokinin receptor ligands (iii)
11/15/2001	WO2001085723A1 Gastrin and cholecystokinin receptor ligands (ii)
11/15/2001	WO2001085722A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001	WO2001085721A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23
11/15/2001	WO2001085720A1 Novel anti-infectives
11/15/2001	WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	WO2001085718A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	WO2001085716A1 2-piperidone compounds for the treatment of cancer
11/15/2001	WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001	WO2001085712A1 Method for the preparation of citalopram
11/15/2001	WO2001085711A1 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or 2-keto-l-gulonate esters
11/15/2001	WO2001085707A1 Para-amine substituted phenylamide glucokinase activators
11/15/2001	WO2001085706A1 Substituted phenylacetamides and their use as glucokinase activators
11/15/2001	WO2001085704A1 Gastrin and cholecystokinin receptor ligands (iv)
11/15/2001	WO2001085702A1 (e)-7(4-fluorophenyl)-6isopropyl2-mesylaminopyrimidin-5-y)-(3r,5s)-dihydroxyhept-6-enoic acid.
11/15/2001	WO2001085701A1 5-ht7 receptor antagonists
11/15/2001	WO2001085700A2 Hiv replication inhibiting pyrimidines and triazines
11/15/2001	WO2001085699A2 Prodrugs of hiv replication inhibiting pyrimidines
11/15/2001	WO2001085698A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001	WO2001085697A1 Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
11/15/2001	WO2001085696A1 Butenoic acids derivatives and their use in the treatment of rhinitis
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2001085694A2 Substituted diamide derivatives useful as motilin antagonists
11/15/2001	WO2001085693A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001	WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001	WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001	WO2001085684A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
11/15/2001	WO2001085681A2 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085676A1 Biocidal polymers based on guanidine salts
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001	WO2001085668A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
11/15/2001	WO2001085664A2 Compounds and methods for regulating bacterial growth and pathogenesis
11/15/2001	WO2001085345A1 Media milling
11/15/2001	WO2001085257A2 Opioid antagonist compositions and dosage forms

1 ... 5965 5966 5967 5968 5969 5970 5971 5972 5973 5974 5975 5976 5977 5978 5979 5980 5981 5982 5983 5984 5985 ... 7860